Answers are grounded in this paper and cite their sources.
Participants would trade PFS for changes in short-term side effects and long-term side effects, although preference heterogeneity existed. Lung cancer treatments that offer less PFS but also less severe side effects might be acceptable to some patients.
No takes yet. Share an insight, caveat, or question.
Janssen et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: